“The SIA acquisition will provide us another action closer to achieving our ambition of starting to be a global segment chief and innovator in breast reconstruction with long run FDA approvals, expenditure in pipeline and proof technology,” explained Jan De Witte, president and CEO, Integra LifeSciences.Before you make an expenditure conclusion